drugset / Trial / NCT00842504
Alternate Day Micafungin: A PK Study in Pediatric Patients
Phase 1
Completed
15 enrolled
Children's Hospital Medical Center, Cincinnati
Astellas Pharma Inc · collab
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to examine the pharmacokinetics of micafungin when it is given on an every other day schedule. The study will determine if every other day micafungin will provide drug exposure equivalent to daily dosing while reducing administration costs and improving patient convenience. Fifteen patients will be enrolled on this study. Blood samples for PK measurements will be obtained for 48 hours following a single dose of micafungin (3 mg/kg).
Timeline
- Start
- 2007-07
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Micafungin | Peptide | 3 mg/kg | Intravenous |